アレルギーケアの世界市場

アレルギーケアの世界市場は2030年までに331億米ドルに達する見込み

2024年に229億米ドルと推定されるアレルギーケアの世界市場は、分析期間2024-2030年にCAGR 6.4％で成長し、2030年には331億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである眼アレルギータイプは、CAGR 5.2％を記録し、分析期間終了時には82億米ドルに達すると予測されます。鼻炎タイプ」の成長率は、分析期間中CAGR 8.0％と推定されます。

米国市場は62億米ドルと推定、中国はCAGR 9.8％で成長予測

米国のアレルギーケア市場は、2024年に62億米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 9.8%で推移し、2030年には67億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.2%と6.1%と予測されています。欧州では、ドイツがCAGR 4.1%で成長すると予測されています。

世界のアレルギーケア市場- 主要動向と促進要因のまとめ

アレルギーケアが世界ヘルスマネジメントの中心になりつつある理由とは？

アレルギーケアは、あらゆる年齢層や地域でアレルギー関連疾患が急増する中、急速に現代ヘルスケアの重要な要素となりつつあります。都市化の進展、環境汚染、気候変動、食事パターンの変化などの要因が総体となって、喘息、アレルギー性鼻炎、湿疹、食物アレルギーなどのアレルギー疾患の有病率を高めています。これらの疾患は、しばしば管理可能であると考えられているが、放置すると生活の質、生産性、長期的な健康を著しく損なう可能性があります。患者やヘルスケア提供者の意識の高まりにより、アレルギーの管理は、早期診断と一貫した治療が重視される、リアクティブなモデルからプロアクティブなモデルへと変化しています。多くのアレルギー疾患は慢性的であるため、患者は長期的な、場合によっては生涯にわたる治療計画を必要とすることが多く、信頼性が高く、利用しやすいアレルギー治療への需要がこれまで以上に急務となっています。さらに、アレルギーの影響は個人だけにとどまらず、特にアレルギーが他の病態を悪化させたり、救急医療につながったりする場合には、より広範な公衆衛生上の影響があります。学校、職場、旅行業界では、このような問題がいかに広範かつ破壊的であるかを認識し、アレルギーに配慮した方針を採用する傾向が強まっています。免疫学的反応の理解が深まるにつれ、アレルギーケアはより個別化され、エビデンスに基づき、より広範な慢性疾患戦略に組み込まれつつあります。統合ケアモデルへのシフトにより、アレルギー治療はもはや孤立したものではなく、予防および地域ヘルスケアの重要な側面として捉えられるようになっています。

診断法と治療法の進歩は、アレルギー管理をどのように変革しているのでしょうか？

技術的・医学的進歩は、アレルギーの診断・治療・モニタリング方法に革命をもたらし、より効率的で個別化されたケアへのアプローチにつながっています。従来の皮膚刺傷や血液を用いたアレルギー検査は、現在、アレルゲン成分を正確に同定できる特異性の高い分子診断によって補完され、場合によっては代替されつつあり、診断精度の向上と治療の個別化が図られています。この精度は、真のアレルギーと過敏症を区別し、誤診や不適切な介入を減らすのに役立ちます。治療薬の面では、皮下注射や舌下錠によるアレルゲン特異的免疫療法（AIT）が、その疾患修飾の可能性から支持を得ており、一部の患者では長期的な緩和や寛解さえももたらしています。オマリズマブやデュピルマブなどのモノクローナル抗体を含む生物学的製剤は、重症のアレルギー患者や治療抵抗性のアレルギー患者、特に喘息や慢性蕁麻疹のような重複する疾患を有する患者に新たな道を開いた。同時に、モバイルヘルスツール、ウェアラブルモニター、コネクテッド吸入器の開発により、患者や介護者は症状を追跡し、薬剤を管理し、リアルタイム分析により再燃を予測することができるようになりました。遠隔医療プラットフォームは、特にサービスが行き届いていない地域や農村部において、専門医による診察をより利用しやすくしています。食物アレルギーのための食事管理ツールや、低アレルギー性製品開発における技術革新は、アレルギー患者の安全性と自律性をさらに高めています。このような技術シフトは、アレルギーケアの有効性を高めるだけでなく、より患者中心の医療を実現し、世界の医療システムのデジタル・トランスフォーメーションに合致したものとなっています。

アレルギーケアの需要を形成している社会的・環境的要因は？

アレルギーケアに対する世界の需要の高まりは、地域によって異なるもの、アレルギー負担に一様に寄与する社会的・環境的な力学に深く影響されています。都市人口、特にアジア、アフリカ、南米の急成長都市では、大気汚染物質、工業化学物質、ダニやカビの胞子などの都市型アレルゲンにさらされる機会が増加しており、アレルギー症状の発症に強く関連する要因となっています。気候変動もまた、花粉の飛散時期を延長し、アレルゲンとなる植物の分布を変化させることによって、住民をより長く、より強いアレルゲン暴露にさらすという重要な役割を果たしています。先進工業国では、「衛生仮説」が再注目されており、幼児期に微生物への曝露が減少するとアレルギーになりやすいことが示唆されています。食生活の変化、室内にいる時間の増加、抗生物質の過剰使用などのライフスタイルの変化は、アレルギー反応を誘発する免疫系の変化をさらに助長します。さらに、一般向けの教育キャンペーンや有名人の擁護によってアレルギーに対する認識が高まり、以前は十分な治療を受けていなかった人々においても、自己診断や市販薬の治療需要が急増しています。教育機関、航空会社、食品メーカーは、重度のアレルギーを持つ人々に対応するために、その慣行を適応させており、このことはアレルギーケアの社会的足跡をさらに物語っています。このような世界的・地域的ダイナミクスは、アレルギー関連症例を増加させるだけでなく、多様な人々のニーズに対応できる、文化的に敏感で、気候に適応し、人口統計学的に適切なケアソリューションの必要性を促しています。

世界のアレルギーケア市場の成長を促進する中核要因は何か？

世界のアレルギーケア市場の成長は、医療、人口統計、技術、経済の各要因の合流によってもたらされます。まず第一に、呼吸器系、皮膚系、食物系、昆虫系など、アレルギー疾患の発生率が着実に上昇しており、長期的な管理を必要とする患者集団が一貫して拡大しています。ヘルスケア・システムが慢性疾患の予防と管理にますますシフトする中、アレルギーは臨床上の優先事項であると同時に公衆衛生上の課題であると認識されています。第二に、バイオテクノロジーと医薬品の進歩は、投資を呼び込み、治療の質を高める革新的な治療法を生み出しています。生物学的製剤、個別化免疫療法、迅速診断ツールの利用可能性の拡大により、治療可能なアレルギー・プロファイルの幅が広がっており、特に複雑なアレルギー疾患や多系統のアレルギー疾患を有する患者にとって重要です。新興市場における可処分所得の増加などの経済的要因により、より多くの人々がアレルギー診断・治療サービスを利用できるようになり、市場拡大のための肥沃な土壌が形成されています。欧州や北米などの地域では、ヘルスケア・インフラの改善や政府の償還政策により、アレルギーケアがより利用しやすく標準化されつつあります。同時に、アレルゲンを含まない食品、化粧品、家庭用品に対する消費者主導の需要が、隣接するアレルギー対応製品市場の成長を促しています。また、デジタルヘルスの導入により、より優れた症状追跡、服薬アドヒアランス、バーチャル診察が可能になり、疾病管理と患者の満足度が向上しています。こうした市場促進要因が相まって、アレルギーケア市場は堅調かつ持続的な成長を遂げ、世界ヘルスの将来において極めて重要なセクターとして位置付けられています。

セグメント

タイプ（眼アレルギータイプ、鼻炎タイプ、喘息タイプ、皮膚アレルギータイプ、食物アレルギータイプ、その他アレルギータイプ）、治療（抗アレルギー薬治療、免疫療法治療）、流通チャネル（病院流通チャネル、オンライン流通チャネル、小売薬局、その他流通チャネル）

調査対象企業の例

• AbbVie Inc.
• Akorn, Inc.
• ALK-Abello A/S
• Almirall, S.A.
• Allergy Therapeutics plc
• Allergopharma GmbH & Co. KG
• AstraZeneca plc
• Bayer AG
• Boehringer Ingelheim GmbH
• DBV Technologies S.A.
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd
• GlaxoSmithKline plc
• HAL Allergy Group
• Johnson & Johnson
• Leti Pharma S.L.
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi S.A.

AI統合

私たちは、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Allergy Care Market to Reach US$33.1 Billion by 2030

The global market for Allergy Care estimated at US$22.9 Billion in the year 2024, is expected to reach US$33.1 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. Eye Allergy Type, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$8.2 Billion by the end of the analysis period. Growth in the Rhinitis Type segment is estimated at 8.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.2 Billion While China is Forecast to Grow at 9.8% CAGR

The Allergy Care market in the U.S. is estimated at US$6.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.7 Billion by the year 2030 trailing a CAGR of 9.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Global Allergy Care Market - Key Trends & Drivers Summarized

Why Is Allergy Care Becoming a Central Focus in Global Health Management?

Allergy care is rapidly becoming a critical component of modern healthcare as allergy-related conditions surge across all age groups and geographies. Factors such as increased urbanization, environmental pollution, climate change, and altered dietary patterns have collectively contributed to a higher prevalence of allergic diseases, including asthma, allergic rhinitis, eczema, and food allergies. These conditions, though often considered manageable, can significantly impair quality of life, productivity, and long-term health when left unaddressed. Growing awareness among patients and healthcare providers has shifted allergy management from a reactive to a proactive model, where early diagnosis and consistent treatment are emphasized. The chronic nature of many allergic conditions means that patients often require long-term, sometimes lifelong, care plans, making the demand for reliable, accessible allergy treatment more urgent than ever. Furthermore, the impact of allergies is not confined to individuals-there are broader public health implications, particularly when allergies exacerbate other medical conditions or result in emergency care. Schools, workplaces, and travel sectors are increasingly adopting allergy-friendly policies in recognition of how widespread and disruptive these issues can be. As the understanding of immunological responses deepens, allergy care is becoming more personalized, evidence-based, and embedded in broader chronic disease strategies. The shift toward integrated care models ensures that allergy treatment is no longer seen in isolation but as a vital aspect of preventive and community healthcare.

How Are Advances in Diagnostics and Therapies Transforming Allergy Management?

Technological and medical advances are revolutionizing how allergies are diagnosed, treated, and monitored, leading to a more efficient and individualized approach to care. Traditional skin-prick and blood-based allergy tests are now being complemented-and in some cases, replaced-by highly specific molecular diagnostics that can identify precise allergen components, improving diagnostic accuracy and tailoring treatment. This precision helps distinguish between true allergies and sensitivities, reducing misdiagnosis and inappropriate interventions. In terms of therapeutics, allergen-specific immunotherapy (AIT), delivered through subcutaneous injections or sublingual tablets, has gained traction for its disease-modifying potential, offering long-term relief and even remission in some patients. Biologic therapies, including monoclonal antibodies such as omalizumab and dupilumab, have opened new avenues for patients with severe or treatment-resistant allergies, particularly those with overlapping conditions like asthma or chronic urticaria. At the same time, the development of mobile health tools, wearable monitors, and connected inhalers are enabling patients and caregivers to track symptoms, manage medications, and anticipate flare-ups through real-time analytics. Telehealth platforms have made specialist consultations more accessible, especially in underserved or rural areas. Dietary management tools for food allergies and innovations in hypoallergenic product development further enhance the safety and autonomy of allergic individuals. These technological shifts are not only enhancing the efficacy of allergy care but also making it more patient-centered and aligned with the digital transformation of healthcare systems globally.

What Social and Environmental Factors Are Shaping Allergy Care Demand Across Regions?

The increasing global demand for allergy care is deeply influenced by socio-environmental dynamics that differ across regions but contribute uniformly to the allergy burden. Urban populations, particularly in fast-growing cities across Asia, Africa, and South America, are experiencing rising exposure to air pollutants, industrial chemicals, and urban allergens such as dust mites and mold spores-factors strongly associated with the onset of allergic conditions. Climate change is also playing a pivotal role by extending pollen seasons and altering the distribution of allergenic plants, thereby exposing populations to longer and more intense allergen exposure. In more industrialized nations, the “hygiene hypothesis” has gained renewed attention, suggesting that reduced exposure to microbes during early childhood may predispose individuals to allergies. Lifestyle changes, including altered diets, increased time indoors, and overuse of antibiotics, further contribute to shifts in the immune system that can trigger allergic responses. Moreover, rising awareness of allergies, driven by public education campaigns and celebrity advocacy, has led to a surge in self-diagnosis and over-the-counter treatment demand, even in populations previously underserved. Educational institutions, airlines, and food manufacturers are adapting their practices to accommodate individuals with severe allergies, further illustrating the social footprint of allergy care. These global and regional dynamics are not only increasing the volume of allergy-related cases but also driving the need for culturally sensitive, climate-adapted, and demographically appropriate care solutions that can meet diverse population needs.

What Are the Core Drivers Fueling Growth in the Global Allergy Care Market?

The growth of the global allergy care market is driven by a confluence of medical, demographic, technological, and economic factors. First and foremost, the steadily rising incidence of allergic diseases-spanning respiratory, skin, food, and insect-based allergies-is creating a consistent and expanding patient population that requires long-term management. With healthcare systems increasingly shifting toward chronic disease prevention and management, allergies have been recognized as both a clinical priority and a public health challenge. Secondly, advancements in biotechnology and pharmaceuticals are generating innovative treatment modalities that attract investment and enhance care quality. The growing availability of biologics, personalized immunotherapy, and rapid diagnostic tools is broadening the range of treatable allergy profiles, especially for patients with complex or multi-system allergic conditions. Economic factors such as rising disposable incomes in emerging markets are allowing more people to access allergy diagnostics and treatment services, creating fertile ground for market expansion. Healthcare infrastructure improvements and government reimbursement policies in regions like Europe and North America are making allergy care more accessible and standardized. Simultaneously, consumer-driven demand for allergen-free foods, cosmetics, and household products is stimulating growth in the adjacent allergy-conscious product markets. Digital health adoption is also enabling better symptom tracking, medication adherence, and virtual consultations, thus improving disease management and patient satisfaction. These combined drivers are setting the stage for robust and sustained growth in the allergy care market, positioning it as a crucial sector in the future of global health.

SCOPE OF STUDY:

The report analyzes the Allergy Care market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type, Other Allergy Types); Treatment (Anti-Allergy Drugs Treatment, Immunotherapy Treatment); Distribution Channel (Hospital Distribution Channel, Online Distribution Channel, Retail Pharmacies, Other Distribution Channels)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• AbbVie Inc.
• Akorn, Inc.
• ALK-Abello A/S
• Almirall, S.A.
• Allergy Therapeutics plc
• Allergopharma GmbH & Co. KG
• AstraZeneca plc
• Bayer AG
• Boehringer Ingelheim GmbH
• DBV Technologies S.A.
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd
• GlaxoSmithKline plc
• HAL Allergy Group
• Johnson & Johnson
• Leti Pharma S.L.
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi S.A.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Allergy Care - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Allergic Conditions Worldwide Spurs Demand for Comprehensive Allergy Care Solutions
  • Increased Awareness and Early Diagnosis Initiatives Propel Growth Across Pediatric and Adult Populations
  • Shifting Consumer Preferences Toward Non-Drowsy and Long-Acting Therapies Expands Addressable Market Opportunity
  • Advancements in Allergen-Specific Immunotherapy Drive Adoption of Personalized Treatment Approaches
  • Here's How Climate Change and Urbanization Accelerate Demand for Respiratory Allergy Management
  • Technological Innovations in At-Home Testing Kits Strengthen Business Case for Decentralized Allergy Care
  • Surge in Food Allergy Incidence Throws the Spotlight on Emergency Treatments and Preventive Strategies
  • Growing Demand for Digital Health Platforms and Tele-Allergy Services Sustains Growth in Remote Monitoring
  • Here's the Story: Rising Cross-Reactivity Cases Fuel Demand for Comprehensive Allergen Profiling
  • Increased Focus on Gut Microbiome Research Drives Development of Preventive Allergy Therapies
  • Expanding Use of AI in Allergy Diagnosis and Management Enhances Efficiency and Patient Outcomes
  • Allergy-Friendly Consumer Products and Clean Label Trends Expand Use-Cases in Retail and Food Sectors
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Allergy Care Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Allergy Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Allergy Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Allergy Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Eye Allergy Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Eye Allergy Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Eye Allergy Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Rhinitis Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Rhinitis Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Rhinitis Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Asthma Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Asthma Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Asthma Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Skin Allergy Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Skin Allergy Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Skin Allergy Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Food Allergies Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Food Allergies Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Food Allergies Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Allergy Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Allergy Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Other Allergy Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Online Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Other Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Hospital Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Hospital Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Hospital Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Anti-Allergy Drugs Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Anti-Allergy Drugs Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Anti-Allergy Drugs Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Immunotherapy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Immunotherapy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Immunotherapy Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Allergy Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: USA 16-Year Perspective for Allergy Care by Type - Percentage Breakdown of Value Sales for Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types for the Years 2014, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: USA 16-Year Perspective for Allergy Care by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: USA 16-Year Perspective for Allergy Care by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs Treatment and Immunotherapy Treatment for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: Canada 16-Year Perspective for Allergy Care by Type - Percentage Breakdown of Value Sales for Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types for the Years 2014, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: Canada 16-Year Perspective for Allergy Care by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: Canada 16-Year Perspective for Allergy Care by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs Treatment and Immunotherapy Treatment for the Years 2014, 2025 & 2030
• JAPAN
  • Allergy Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: Japan 16-Year Perspective for Allergy Care by Type - Percentage Breakdown of Value Sales for Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types for the Years 2014, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: Japan 16-Year Perspective for Allergy Care by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: Japan 16-Year Perspective for Allergy Care by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs Treatment and Immunotherapy Treatment for the Years 2014, 2025 & 2030
• CHINA
  • Allergy Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 68: China Recent Past, Current & Future Analysis for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: China 16-Year Perspective for Allergy Care by Type - Percentage Breakdown of Value Sales for Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types for the Years 2014, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: China 16-Year Perspective for Allergy Care by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: China 16-Year Perspective for Allergy Care by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs Treatment and Immunotherapy Treatment for the Years 2014, 2025 & 2030
• EUROPE
  • Allergy Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Allergy Care by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Allergy Care by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: Europe 16-Year Perspective for Allergy Care by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: Europe 16-Year Perspective for Allergy Care by Type - Percentage Breakdown of Value Sales for Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types for the Years 2014, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: Europe 16-Year Perspective for Allergy Care by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: Europe 16-Year Perspective for Allergy Care by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs Treatment and Immunotherapy Treatment for the Years 2014, 2025 & 2030
• FRANCE
  • Allergy Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 89: France Recent Past, Current & Future Analysis for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: France 16-Year Perspective for Allergy Care by Type - Percentage Breakdown of Value Sales for Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types for the Years 2014, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: France 16-Year Perspective for Allergy Care by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: France 16-Year Perspective for Allergy Care by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs Treatment and Immunotherapy Treatment for the Years 2014, 2025 & 2030
• GERMANY
  • Allergy Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: Germany 16-Year Perspective for Allergy Care by Type - Percentage Breakdown of Value Sales for Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types for the Years 2014, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Germany 16-Year Perspective for Allergy Care by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Germany 16-Year Perspective for Allergy Care by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs Treatment and Immunotherapy Treatment for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: Italy 16-Year Perspective for Allergy Care by Type - Percentage Breakdown of Value Sales for Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types for the Years 2014, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: Italy 16-Year Perspective for Allergy Care by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: Italy 16-Year Perspective for Allergy Care by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs Treatment and Immunotherapy Treatment for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Allergy Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 116: UK Recent Past, Current & Future Analysis for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: UK 16-Year Perspective for Allergy Care by Type - Percentage Breakdown of Value Sales for Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types for the Years 2014, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: UK 16-Year Perspective for Allergy Care by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: UK 16-Year Perspective for Allergy Care by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs Treatment and Immunotherapy Treatment for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: Spain 16-Year Perspective for Allergy Care by Type - Percentage Breakdown of Value Sales for Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types for the Years 2014, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: Spain 16-Year Perspective for Allergy Care by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Spain 16-Year Perspective for Allergy Care by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs Treatment and Immunotherapy Treatment for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Russia 16-Year Perspective for Allergy Care by Type - Percentage Breakdown of Value Sales for Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types for the Years 2014, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Russia 16-Year Perspective for Allergy Care by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Russia 16-Year Perspective for Allergy Care by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs Treatment and Immunotherapy Treatment for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 16-Year Perspective for Allergy Care by Type - Percentage Breakdown of Value Sales for Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types for the Years 2014, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 16-Year Perspective for Allergy Care by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 16-Year Perspective for Allergy Care by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs Treatment and Immunotherapy Treatment for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Allergy Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Allergy Care by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Allergy Care by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 16-Year Perspective for Allergy Care by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 16-Year Perspective for Allergy Care by Type - Percentage Breakdown of Value Sales for Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types for the Years 2014, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 16-Year Perspective for Allergy Care by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 16-Year Perspective for Allergy Care by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs Treatment and Immunotherapy Treatment for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Allergy Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: Australia 16-Year Perspective for Allergy Care by Type - Percentage Breakdown of Value Sales for Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types for the Years 2014, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: Australia 16-Year Perspective for Allergy Care by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: Australia 16-Year Perspective for Allergy Care by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs Treatment and Immunotherapy Treatment for the Years 2014, 2025 & 2030
• INDIA
  • Allergy Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 173: India Recent Past, Current & Future Analysis for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: India 16-Year Perspective for Allergy Care by Type - Percentage Breakdown of Value Sales for Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types for the Years 2014, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: India 16-Year Perspective for Allergy Care by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: India 16-Year Perspective for Allergy Care by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs Treatment and Immunotherapy Treatment for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: South Korea 16-Year Perspective for Allergy Care by Type - Percentage Breakdown of Value Sales for Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types for the Years 2014, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: South Korea 16-Year Perspective for Allergy Care by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: South Korea 16-Year Perspective for Allergy Care by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs Treatment and Immunotherapy Treatment for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Allergy Care by Type - Percentage Breakdown of Value Sales for Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types for the Years 2014, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Allergy Care by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 16-Year Perspective for Allergy Care by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs Treatment and Immunotherapy Treatment for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Allergy Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Allergy Care by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Allergy Care by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Latin America 16-Year Perspective for Allergy Care by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Latin America 16-Year Perspective for Allergy Care by Type - Percentage Breakdown of Value Sales for Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types for the Years 2014, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Latin America 16-Year Perspective for Allergy Care by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Latin America 16-Year Perspective for Allergy Care by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs Treatment and Immunotherapy Treatment for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Argentina 16-Year Perspective for Allergy Care by Type - Percentage Breakdown of Value Sales for Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types for the Years 2014, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: Argentina 16-Year Perspective for Allergy Care by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: Argentina 16-Year Perspective for Allergy Care by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs Treatment and Immunotherapy Treatment for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: Brazil 16-Year Perspective for Allergy Care by Type - Percentage Breakdown of Value Sales for Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types for the Years 2014, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: Brazil 16-Year Perspective for Allergy Care by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: Brazil 16-Year Perspective for Allergy Care by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs Treatment and Immunotherapy Treatment for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: Mexico 16-Year Perspective for Allergy Care by Type - Percentage Breakdown of Value Sales for Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types for the Years 2014, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: Mexico 16-Year Perspective for Allergy Care by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: Mexico 16-Year Perspective for Allergy Care by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs Treatment and Immunotherapy Treatment for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 16-Year Perspective for Allergy Care by Type - Percentage Breakdown of Value Sales for Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types for the Years 2014, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 16-Year Perspective for Allergy Care by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 16-Year Perspective for Allergy Care by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs Treatment and Immunotherapy Treatment for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Allergy Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Allergy Care by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Allergy Care by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: Middle East 16-Year Perspective for Allergy Care by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: Middle East 16-Year Perspective for Allergy Care by Type - Percentage Breakdown of Value Sales for Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types for the Years 2014, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: Middle East 16-Year Perspective for Allergy Care by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: Middle East 16-Year Perspective for Allergy Care by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs Treatment and Immunotherapy Treatment for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Iran 16-Year Perspective for Allergy Care by Type - Percentage Breakdown of Value Sales for Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types for the Years 2014, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Iran 16-Year Perspective for Allergy Care by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Iran 16-Year Perspective for Allergy Care by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs Treatment and Immunotherapy Treatment for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Israel 16-Year Perspective for Allergy Care by Type - Percentage Breakdown of Value Sales for Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types for the Years 2014, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: Israel 16-Year Perspective for Allergy Care by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: Israel 16-Year Perspective for Allergy Care by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs Treatment and Immunotherapy Treatment for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 16-Year Perspective for Allergy Care by Type - Percentage Breakdown of Value Sales for Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types for the Years 2014, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 16-Year Perspective for Allergy Care by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 16-Year Perspective for Allergy Care by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs Treatment and Immunotherapy Treatment for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: UAE 16-Year Perspective for Allergy Care by Type - Percentage Breakdown of Value Sales for Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types for the Years 2014, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: UAE 16-Year Perspective for Allergy Care by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: UAE 16-Year Perspective for Allergy Care by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs Treatment and Immunotherapy Treatment for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 16-Year Perspective for Allergy Care by Type - Percentage Breakdown of Value Sales for Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types for the Years 2014, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 16-Year Perspective for Allergy Care by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 16-Year Perspective for Allergy Care by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs Treatment and Immunotherapy Treatment for the Years 2014, 2025 & 2030
• AFRICA
  • Allergy Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Allergy Care by Type - Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 307: Africa 16-Year Perspective for Allergy Care by Type - Percentage Breakdown of Value Sales for Eye Allergy Type, Rhinitis Type, Asthma Type, Skin Allergy Type, Food Allergies Type and Other Allergy Types for the Years 2014, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Allergy Care by Distribution Channel - Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 310: Africa 16-Year Perspective for Allergy Care by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Retail Pharmacies, Other Distribution Channels and Hospital Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Allergy Care by Treatment - Anti-Allergy Drugs Treatment and Immunotherapy Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 313: Africa 16-Year Perspective for Allergy Care by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs Treatment and Immunotherapy Treatment for the Years 2014, 2025 & 2030

IV. COMPETITION